Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

AIMS: Sodium-glucose co-transporter 2 (SGLT2) inhibitors improve cardiovascular outcomes in diverse patient populations, but their mechanism of action requires further study. The aim is to explore the effect of empagliflozin on the circulating levels of intracellular proteins in patients with heart...

Descripción completa

Detalles Bibliográficos
Autores principales: Zannad, Faiez, Ferreira, João Pedro, Butler, Javed, Filippatos, Gerasimos, Januzzi, James L, Sumin, Mikhail, Zwick, Matthias, Saadati, Maral, Pocock, Stuart J, Sattar, Naveed, Anker, Stefan D, Packer, Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769969/
https://www.ncbi.nlm.nih.gov/pubmed/36017745
http://dx.doi.org/10.1093/eurheartj/ehac495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769969/
https://www.ncbi.nlm.nih.gov/pubmed/36017745
http://dx.doi.org/10.1093/eurheartj/ehac495

Ejemplares similares